Slide 1

VAERS Analysis SaneVax Inc. 2012

Slide 2

Total Adverse Events Gardasil (HPV4)was approved for use in June 2006. This chart represents the vaccines most frequently reported in the VAERS system versus all other vaccines listed in the database since that time. It includes vaccinations given in combination with other vaccines.

Slide 3

Total Reports in VAERS Once again, the most reported vaccines in the VAERS database this time only those vaccines that were not administered with any others. HPV4 is Gardasil.

Slide 4

Life Threatening Events: Female This and all of the following charts compare the HPV vaccines Gardasil and Cervarix to the rest of the vaccines in the VAERS database. Note that in the 12-17 age group HPV vaccines account for 83% of all life threatening events.

Slide 5

Life Threatening: Male HPV vaccines were approved for use in males in November 2011. Already, you can see a significant percentage of life-threatening events in the male population.

Slide 6

Life Threatening: Gender Unknown VAERS reports do not always list the gender of the person reporting an adverse reaction after vaccinations. This chart illustrates the breakdown of those reports.

Slide 7

Life Threatening: Total Events View the percentages of all life-threatening events in the VAERS database, without regard to gender, when HPV vaccines are compared to all other reportable vaccines.

Slide 8

Emergency Room Visits: Female Gardasil and Cervarix account for between 34 and 73% of all female emergency room visits reported to VAERS since HPV vaccines were approved by the FDA.

Slide 9

Emergency Room Visits: Male Male emergency room visits reported after HPV vaccines compared to all other vaccines. Keep in mind these only date from November 2011.

Slide 10

Emergency Room Visits: Gender Unknown Emergency room visits where gender was not reported.

Slide 11

Emergency Room Visits: Total No matter which age group you look at, Gardasil and Cervarix account for a significant percentage of all ER visits reported VAERS database. Keep in mind, there are 77 other FDA approved vaccines in the VAERS database.

Slide 12

Hospitalized: Female Is there any reason that one type of vaccine should ever account for 81% of the hospitalizations in a specific age group of young women? Does this alone not raise a red flag?

Slide 13

Hospitalized: Male Less than a year after HPV vaccines were approved for use in males, between 1% and 6% of all reported male hospitalizations are occurring after HPV vaccines.

Slide 14

Hospitalized: Gender Unknown One has to wonder how someone can be hospitalized without knowing their gender, but these are the percentages of that type of report to VAERS.

Slide 15

Hospitalized: Total 70% of all hospitalizations reported in the 12-17 year old group was after either Gardasil or Cervarix. What is wrong with this picture?

Slide 16

Extended Hospital Stay: Female One has to ask why anyone would risk an extended hospital stay to prevent HPV infections when 90% of them clear on their own with no symptoms or medical intervention.

Slide 17

Extended Hospital Stay: Male 76 vaccines and HPV vaccines already account for 2-5% of extended hospital stays for males.

Slide 18

Extended Hospital Stay: Total Of all reported extended hospital stays, Gardasil and Cervarix account for 34% of all reports in the 17-44 year old group even though these vaccines are not recommended for anyone over age 26.

Slide 19

Did Not Recover: Female Why does a single type of vaccine account for such a large percentage of did not recover events.

Slide 20

Did Not Recover: Male Males who have not recovered from new medical conditions after vaccinations.

Slide 21

Did Not Recover: Gender Unknown 14-44% of the unknown gender reports have not recovered from new medical conditions after HPV vaccinations.

Slide 22

Did Not Recover: Total By FDA definition, any new medical condition occurring after vaccination is an adverse event. Why is such a large percentage of those who have not recovered being reported after HPV vaccines?

Slide 23

Disabled: Female When looking at the next few charts, one has to wonder what quality of life is left for those classified as disabled after Gardasil or Cervarix vaccinations.

Slide 24

Disabled: Male This graph illustrates males who have become disabled after HPV vaccines they took to either protect the women they meet in the future, or protect themselves from genital warts and/or rare forms of cancer.

Slide 25

Disabled: Gender Unknown There may not be many reports in this area, but each of them was a person with a family left to cope with the disability. These are real people.

Slide 26

Disabled: Total Well over 500 people who are left disabled after HPV vaccines.

Slide 27

Serious: Female Considering the number of FDA approved vaccines, there is no way two of them should account for such a large percentage of serious adverse events.

Slide 28

Serious: Male Please remember males have not been taking HPV vaccines for very long.

Slide 29

Serious: Gender Unknown What kind of hospital bills did these families end up with in the name of protecting their children from a disease they have very little chance of contracting?

Slide 30

Serious: Total Do the families of these victims still think the benefits of HPV vaccination outweigh the risks?

Slide 31

Deaths: Female Families who have paid the ultimate price for the greater good are told these deaths were coincidental, population-based, just chance, or unexplainable.

Slide 32

Deaths: Male Additional acceptable collateral damage?

Slide 33

Deaths: Gender Unknown When will someone decide to actually investigate these unexplained deaths?

Slide 34

Deaths: Total How can anyone discount these percentages? No one knows what the true figures are. Even the CDC admits that only 1-10% of adverse reactions are actually reported to the Vaccine Adverse Event Reporting System. When you add a zero or two to all of the figures in the previous pages, the picture is not very pretty. When will government health officials admit the advertised benefits of HPV vaccines do not outweigh the real risks?

Slide 35

SaneVax would like to express a heartfelt thanks to Rosemary Mathis and Janny Stokvis for compiling all of this data and creating this set of revealing charts. We sincerely appreciate all of the hard work it took to accomplish this task. Visit SaneVax Inc. for more information on HPV vaccines.SaneVax Inc